EUVIMEDEUVIMED entdecken
Crossref

Discovery of 5-(Pyrimidin-2-ylamino)-1 H -indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer

Jingbo Qin, Boning Niu, Xiaohui Chen, Cheng Hu, Sheng Lu, Hongsheng Li, Weihao Liu, Jiayi Li, Zihao Teng, Yinghuang Yang, Hongyu Hu, Yang Xu und 5 weitere

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c01336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Jingbo Qin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sci…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The orphan nuclear receptor Nur77 has been validated as a potential drug target for treating breast cancer. Therefore, focusing on the SAR study of the lead 8b (KDSPR(Nur77) = 354 nM), we found the active compound ja which exhibited improved Nur77-binding capability (KDSPR(Nur77) = 91 nM) and excellent antiproliferative activities against breast cancer cell lines. Interestingly, ja acted as a potent and selective Nur77 antagonist, displaying good potency against triple-negative breast cancer (TNBC) cell lines but did not inhibit human normal breast cancer cell line MCF-10A (SI > 20). Exceptionally, ja Nur77-dependently caused mitochondria dysfunction and induced the caspase-dependent apoptosis by mediating the TP53 phosphorylation pathway. Moreover, ja significantly suppressed MDA-MB-231 xenograft tumor growth but had no apparent side effects in mice and zebrafish. Overall, ja demonstrated to be the first Nur77 modulator mediating the TP53 phosphorylation pathway that has the potential as a novel anticancer agent for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsAntineoplastic AgentsHumansAnimalsMiceCell Line, TumorZebrafishApoptosisIndolesCell Proliferation

Substanzen

Antineoplastic AgentsIndoles

Autor:innen und Institutionen

  • Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cellular Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen 361102, China.
  • Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.
  • Tongji School of Pharmacy, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Clinical Laboratory, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, China.
  • Xingzhi College, Zhejiang Normal University, Lanxi 321004, China.

ORCID-Profile: Shuaidong Huo, Yingkun Qiu, Hu Zhou, Meijuan Fang

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Qin, J., Niu, B., Chen, X., Hu, C., Lu, S., Li, H., Liu, W., Li, J., Teng, Z., Yang, Y., Hu, H., Xu, Y., Huo, S., Wu, Z., Qiu, Y., Zhou, H., & Fang, M. (2023). Discovery of 5-(Pyrimidin-2-ylamino)-1 H -indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01336

Vancouver

Qin J, Niu B, Chen X, Hu C, Lu S, Li H, et al. Discovery of 5-(Pyrimidin-2-ylamino)-1 H -indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01336

BibTeX
@article{Qin2023,
  author = {Qin, Jingbo and Niu, Boning and Chen, Xiaohui and Hu, Cheng and Lu, Sheng and Li, Hongsheng and Liu, Weihao and Li, Jiayi and Teng, Zihao and Yang, Yinghuang and Hu, Hongyu and Xu, Yang and Huo, Shuaidong and Wu, Zhen and Qiu, Yingkun and Zhou, Hu and Fang, Meijuan},
  title = {Discovery of 5-(Pyrimidin-2-ylamino)-1 H -indole-2-carboxamide Derivatives as Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c01336}
}
Kostenlos starten →